查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2018613

農業生物技術市場：按產品類型、技術、作物類型、應用和最終用戶分類－2026-2032年全球市場預測

Agricultural Biotechnology Market by Product Type, Technology, Crop Type, Application, End-user - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，農業生物技術市場價值將達到 1,586.9 億美元，到 2026 年將成長到 1,692.4 億美元，到 2032 年將達到 2,571.8 億美元，複合年成長率為 7.14%。

主要市場統計數據
基準年 2025 1586.9億美元
預計年份：2026年 1692.4億美元
預測年份 2032 2571.8億美元
複合年成長率 (%) 7.14%

對塑造農業生物技術未來的科學、監管和商業交叉趨勢進行了簡潔而又全面的概述。

農業生物技術產業正處於轉折點，隨著科學創新、法規演變和貿易動態變化的交匯，農業實踐和商業策略正在被重新定義。本文概述了對企業主管和技術領導者而言最重要的促進因素：具體而言，包括基因編輯平台的成熟、微生物解決方案應用的不斷擴展、高通量基因組學在育種流程中的整合，以及診斷和數位化工具在作物和牲畜管理中日益重要的作用。

近期科學突破、共同研究模式和數位診斷如何協同加速創新並重塑農業生物技術的商業化路徑。

農業生物技術領域正經歷一場變革，創新正在改變技術發展的速度和範圍。基於 CRISPR 的基因編輯和其他精準工程工具正在縮短改良目標性狀所需的時間，使育​​種週期能夠更快地應對新出現的生物和非生物威脅。同時，基因組學和 DNA定序的進步使數據生成更加普及，為育種者和研究人員提供了關於性狀結構的可操作性見解，而標記輔助選擇則與新的基因編輯技術相輔相成。

基於證據的檢驗，探討 2025 年美國關稅措施將如何重塑農業生物技術領域的供應鏈、國際研究合作和商業化策略。

美國在2025年實施的關稅和貿易政策調整對整個農業生物技術價值鏈產生了複雜的連鎖反應，影響了投入品、跨國合作以及下游商業化策略。對某些進口商品徵收的關稅增加了專用實驗室試劑、高價值育種材料和某些生物製品的直接成本，迫使製造商和研究機構重新評估籌資策略和庫存管理。為應對這一局面，採購團隊透過供應商多元化和加快替代供應商的認證來減輕短期衝擊。

詳細的細分概述揭示了技術分類、作物類別、應用優先順序和最終用戶概況如何共同決定研究重點和商業化路徑。

要了解市場動態，需要詳細掌握技術分類、產品類型、重點作物、應用領域和終端用戶生態系統。整體情況涵蓋生物資訊學、基因工程、基因組學和分子標記、微生物技術、分子診斷、合成生物學和組織培養。基因工程進一步細分為CRISPR/Cas9和基因編輯以及基因改造技術，而基因組學和分子標記則延伸至DNA定序和標記輔助選擇。產品類型多種多樣，從動物生物技術產品和生物肥料到生物農藥、基因改造作物、基因改造種子，甚至植物生長調節劑，每種產品都需要其獨特的監管、生產和分銷模式。

美洲、歐洲、中東和非洲以及亞太地區的區域法規結構、基礎設施能力和技術採用準備如何塑造差異化的商業化策略。

區域趨勢對整個農業生物技術領域的技術採納模式、法規結構和商業策略都具有顯著影響。在美洲，創新中心和成熟的種子及生物技術公司支撐著一個強大的生態系統，該系統強調可擴展的商業化、一體化的供應鏈以及積極的公私夥伴關係。該地區通常在新型性狀的田間試驗中發揮主導作用，並高度關注多功能作物，因為性狀改良能夠為農場帶來即時的效益。

領先的農業生物技術公司正在利用戰略企業趨勢和能力建設趨勢，將科學平台擴充性為可擴展和具有韌性的商業業務。

農業生物技術領域的主要企業正面臨著一個複雜的環境，其特點是技術快速變革、監管嚴格以及客戶期望不斷變化。市場參與企業正透過多種策略手段實現差異化，包括重點投資基因編輯和微生物解決方案的研發、與種子企業和研究機構建立策略合作夥伴關係，以及透過垂直整合確保獲得關鍵投入和分銷管道。許多公司也將監管科學能力和公共事務放在首位，以促進核准並建立相關人員的信任。

為行業領導者制定清晰、優先的營運和策略步驟，以加快採用速度、降低貿易和供應風險，並使監管合規與產品開發保持一致。

產業領導者應優先採取一系列切實可行的措施來管理監管、市場和供應鏈風險，同時充分利用技術進步。首先，在研發生命週期的早期階段就應整合監理策略，協調測試設計、資料產生和對外溝通。這將減少後期階段的阻力，並加快複雜性狀解決方案的上市速度。其次，應投資擴大區域製造地並實現供應鏈多元化，以最大限度地降低跨境關稅波動的影響，並確保及時獲得關鍵試劑和生物原料。

採用透明的跨領域研究途徑，結合專家訪談、文獻整合和可靠的檢驗，確保研究結果可操作且檢驗。

本分析的調查方法結合了定性和定量方法，旨在確保研究結果的穩健性、透明度和可重複性。主要研究工作包括對研發部門高階領導、監管專家、採購負責人和農民代表進行結構化訪談，以獲取有關開發平臺、供應鏈和市場推廣動態的第一手經驗。此外，研究還諮詢了政策專家和技術顧​​問，以獲取有關不斷變化的法規結構和貿易政策影響的背景資訊。

整合技術潛力、供應鏈韌性和相關人員參與，為實現農業生物技術的永續影響制定切實可行的路徑。

總之，農業生物技術領域正日趨成熟，成為一個多方面的生態系統，其中科學進步、監管協調、供應鏈韌性和相關人員參與對成功至關重要。基因編輯、基因組學、微生物解決方案和數位診斷技術的融合，使得針對性干預成為可能，從而顯著提高不同種植系統和畜牧業的韌性和生產力。然而，將科學潛力轉化為永續的市場成果，需要對研發、監管合規、生產製造和市場推廣工作進行策略性協調。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 農業生技市場：依產品類型分類

  • 動物生物技術產品
  • 生物肥料
  • 生物農藥
  • 基因改造作物/基因改造種子
  • 植物生長調節劑

第9章：農業生物技術市場：依技術分類

  • 生物資訊學
  • 基因工程
    • CRISPR/Cas9 與基因編輯
    • 基因工程技術
  • 基因組學和分子標記
    • DNA定序
    • 標記輔助選擇（MAS）
  • 微生物生物技術
  • 分子診斷
  • 合成生物學
  • 組織培養

第10章 農業生物技術市場：依作物類型分類

  • 糧食
    • 大麥
    • 玉米
    • 米
    • 小麥
  • 水果和蔬菜
  • 油籽
    • 油菜籽
    • 大豆
    • 向日葵
  • 豆子
    • 鷹嘴豆
    • 扁豆
    • 豌豆

第11章 農業生技市場：依應用領域分類

  • 作物改良
    • 非生物脅迫耐受性
    • 抗蟲害
    • 產量提升
  • 疾病管理
  • 環境永續性
  • 牲畜健康和生產力
  • 土壤肥力管理

第12章 農業生技市場：依最終用戶分類

  • 農業合作社
  • 生技公司
  • 農民和生產者
  • 政府/監管機構
  • 研究機構
  • 種子生產商

第13章 農業生技市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 農業生技市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 農業生物技術市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國農業生技市場

第17章：中國農業生物技術市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • ADAMA Ltd
  • Agrinos AS
  • Andermatt Biocontrol AG
  • Arcadia Biosciences, Inc.
  • BASF SE
  • Bayer CropScience AG
  • Bioworks, Inc.
  • Certis USA LLC
  • CIBO Technologies, Inc.
  • Corteva, Inc.
  • Evogene Ltd.
  • FMC Corporation
  • Indigo Ag, Inc.
  • Koppert Biological Systems NV
  • KWS SAAT SE & Co. KGaA
  • Limagrain
  • Marrone Bio Innovations, Inc.
  • Nufarm Limited
  • Performance Plants Inc.
  • Pivot Bio, Inc.
  • Symbiomics SA
  • Syngenta AG
  • UPL Limited
  • Valent BioSciences LLC
Product Code: MRR-221461476867

The Agricultural Biotechnology Market was valued at USD 158.69 billion in 2025 and is projected to grow to USD 169.24 billion in 2026, with a CAGR of 7.14%, reaching USD 257.18 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 158.69 billion
Estimated Year [2026] USD 169.24 billion
Forecast Year [2032] USD 257.18 billion
CAGR (%) 7.14%

A concise yet comprehensive orientation to the converging scientific, regulatory, and commercial forces shaping the future of agricultural biotechnology

The agricultural biotechnology sector stands at an inflection point where scientific innovation, regulatory evolution, and shifting trade dynamics intersect to redefine agronomic practice and commercial strategy. This introduction synthesizes the drivers that matter most to executives and technical leaders: the maturation of gene editing platforms, expanded applications of microbial solutions, the integration of high-throughput genomics into breeding pipelines, and the increasing role of diagnostic and digital tools in crop and livestock management.

Across geographies and commodity classes, stakeholders face a common imperative to translate laboratory advances into field-ready solutions that deliver measurable improvements in resilience, productivity, and sustainability. Concurrently, institutional actors such as research centers, seed manufacturers, and regulatory agencies are navigating new frameworks for data governance, intellectual property, and public acceptance. As a result, the pathway from discovery to adoption is becoming more iterative and collaborative, with partnerships between biotech firms, seed houses, and farmer cooperatives playing a pivotal role.

This introduction sets the stage for an executive-level exploration of transformative shifts, policy impacts, market segmentation nuance, regional dynamics, corporate strategies, and actionable recommendations. It highlights the need for integrated approaches that balance technological ambition with pragmatic deployment, stakeholder engagement, and alignment to evolving regulatory norms.

How recent scientific breakthroughs, collaborative research models, and digital diagnostics are jointly accelerating innovation and reshaping commercialization pathways in agricultural biotechnology

The landscape of agricultural biotechnology is undergoing transformative shifts driven by innovations that are altering both the pace and scope of what is technically feasible. CRISPR-based gene editing and other precision engineering tools have reduced the time required to generate targeted trait improvements, enabling breeding cycles that are more responsive to emerging biotic and abiotic threats. At the same time, advances in genomics and DNA sequencing have democratized data generation, providing breeders and researchers with actionable insights into trait architecture and enabling marker-assisted selection to complement newer editing methods.

Microbial biotechnology and synthetic biology are expanding the toolkit for soil health, nutrient management, and biological pest control, fostering integrated solutions that reduce reliance on chemical inputs. Molecular diagnostics and digital phenotyping are enabling earlier detection of disease and stress, which in turn improves decision-making and management effectiveness. These technological shifts are accompanied by institutional changes: collaborative research models between private companies and public research institutions are proliferating, and open-data initiatives are accelerating knowledge diffusion.

Collectively, these shifts are reshaping product development pathways, shortening time-to-field for certain classes of innovations while increasing the importance of regulatory strategy, public engagement, and value-chain integration. As a result, organizations that align R&D priorities with scalable delivery models and stakeholder trust-building will be better positioned to translate scientific advances into commercially and socially viable outcomes.

An evidence-based examination of how the 2025 United States tariff measures reshaped supply chains, international research collaboration, and commercialization strategies across agricultural biotechnology

The imposition of tariffs and trade policy adjustments by the United States in 2025 created a complex ripple across agricultural biotechnology value chains, affecting inputs, cross-border collaborations, and downstream commercialization strategies. Tariffs on certain categories of imports raised the direct cost of specialized lab reagents, high-value breeding material, and certain bioproducts, which compelled manufacturers and research organizations to reassess sourcing strategies and inventory management. In response, procurement teams diversified supplier bases and accelerated qualification of alternate vendors to mitigate near-term disruptions.

Trade barriers also influenced international research collaborations, as increased customs scrutiny and longer lead times complicated the transfer of biological materials and sequencing services between institutions. Consequently, some collaborative projects restructured logistics to rely more on in-country capacity or cloud-based data exchange rather than physical sample transfers. Moreover, tariffs elevated the strategic importance of regional manufacturing and local production of critical inputs, prompting investment decisions aimed at building resilient supply chains and reducing exposure to trade volatility.

From a commercialization perspective, tariff-driven cost pressures sharpened the focus on operational efficiency and route-to-market optimization. Companies prioritized product formats and packaging that minimized cross-border complexities while emphasizing regulatory harmonization and bilateral agreements to facilitate smoother trade. In sum, the tariff environment catalyzed a reassessment of supply chain resilience, collaboration modalities, and market access strategies across the agricultural biotechnology ecosystem.

In-depth segmentation overview revealing how technology classes, crop categories, application priorities, and end-user profiles jointly determine research focus and commercialization pathways

Understanding market dynamics requires a granular appreciation of technology classes, product types, crop focus, application domains, and the end-user ecosystem. The technology landscape spans bioinformatics, genetic engineering, genomics and molecular markers, microbial biotechnology, molecular diagnostics, synthetic biology, and tissue culture, with genetic engineering further differentiated into CRISPR/Cas9 and gene editing versus transgenic approaches, while genomics and molecular markers extend into DNA sequencing and marker-assisted selection. Product types encompass a range from animal biotechnology products and biofertilizers to biopesticides, genetically modified crops and transgenic seeds, as well as plant growth regulators, each demanding distinct regulatory, production, and distribution models.

Crop segmentation highlights the importance of cereals, fruits and vegetables, oilseeds, and pulses; within cereals, specific attention to barley, maize, rice, and wheat reveals divergent breeding priorities and trait portfolios, and within oilseeds and pulses the subcategories of rapeseed, soybean, sunflower, chickpea, lentil, and pea illuminate varied agronomic and market drivers. Applications cluster around crop improvement, disease management, environmental sustainability, livestock health and productivity, and soil fertility management, with crop improvement itself branching into abiotic stress tolerance, pest resistance, and yield enhancement. End users range from agricultural cooperatives and biotech companies to farmers and growers, government and regulatory agencies, research institutions, and seed manufacturers, each exerting different influence on adoption cycles, purchasing behavior, and product design.

Taken together, these segmentation lenses reveal how technology choices intersect with crop and application priorities to shape R&D pipelines and commercialization paths. For example, a gene editing approach tailored for abiotic stress tolerance in maize will engage different regulatory pathways and end-user adoption dynamics than a microbial biopesticide designed for integrated pest management in vegetable systems. Recognizing these nuanced interdependencies is essential for aligning product development, stakeholder engagement, and go-to-market strategies.

How regional regulatory frameworks, infrastructure capacity, and adoption readiness across the Americas, Europe Middle East & Africa, and Asia-Pacific shape differentiated commercialization strategies

Regional dynamics materially influence technology adoption patterns, regulatory frameworks, and commercial strategies across the agricultural biotechnology landscape. In the Americas, innovation hubs and well-established seed and biotech firms anchor a robust ecosystem that emphasizes scalable commercialization, integrated supply chains, and active private-public research partnerships. This region often leads in field trial deployment for novel traits and maintains a strong emphasis on commodity-oriented crops where trait improvements deliver immediate farm-level benefits.

The Europe, Middle East & Africa region presents a heterogeneous environment where regulatory approaches, market acceptance, and agroecological priorities vary widely. Regulatory stringency and public engagement shape adoption pathways, particularly for genetic engineering and novel biologicals, while climate adaptation and sustainability goals drive interest in solutions oriented toward environmental resilience. Meanwhile, differing market maturity levels across countries necessitate tailored entry strategies and local stakeholder dialogues.

In the Asia-Pacific region, high population density and diverse cropping systems create urgent demand for productivity enhancements, stress tolerance, and disease management solutions. Rapid adoption of digital tools and diagnostic platforms in some markets complements an active seed industry and growing domestic biotech capability. Across all regions, the interplay between local regulatory frameworks, infrastructure capacity, and supply chain robustness determines the feasibility and pace of deployment, making regional adaptation a central element of corporate strategy and public policy planning.

Strategic corporate moves and capability-building trends that leading agricultural biotechnology firms use to translate scientific platforms into scalable and resilient commercial operations

Leading companies in agricultural biotechnology are navigating a complex environment marked by rapid technological change, regulatory scrutiny, and evolving customer expectations. Market participants are differentiating through several strategic levers including targeted R&D investment in gene editing and microbial solutions, strategic alliances with seed companies and research institutions, and vertical integration to secure access to critical inputs and distribution channels. Many firms are also prioritizing regulatory science capacity and public affairs to facilitate approvals and build stakeholder trust.

Corporate strategies increasingly emphasize platform capabilities that enable multiple product lines, such as modular gene editing toolkits, standardized microbial production processes, and integrated diagnostics that link trait deployment with on-farm management practices. Partnerships and licensing deals continue to play a prominent role in accessing complementary expertise, accelerating time-to-trial, and scaling commercialization. Additionally, supply chain resilience has become a board-level concern, prompting investments in regional manufacturing, redundancy planning, and vendor diversification.

From a talent perspective, firms are recruiting multidisciplinary teams that combine molecular biologists, regulatory scientists, data analysts, and field agronomists to bridge R&D and commercialization. Intellectual property strategies are being balanced with open innovation models in select domains to foster ecosystem development while protecting core assets. Collectively, these corporate moves underscore a shift toward integrated business models that couple scientific capability with commercial execution and stakeholder engagement.

Clear, prioritized operational and strategic steps for industry leaders to accelerate adoption, mitigate trade and supply risks, and align regulatory engagement with product development

Industry leaders should prioritize a set of actionable initiatives to capitalize on technological advances while managing regulatory, market, and supply chain risks. First, embed regulatory strategy early in the R&D lifecycle to align trial design, data generation, and public communication; this reduces friction at later stages and accelerates path-to-market for complex trait solutions. Second, invest in regional manufacturing and supply chain diversification to minimize exposure to cross-border tariff volatility and to ensure timely access to critical reagents and biological inputs.

Third, cultivate partnerships across the value chain, including seed manufacturers, agricultural cooperatives, research institutions, and service providers, to co-develop delivery mechanisms that address end-user constraints and adoption barriers. Fourth, integrate digital diagnostics and data analytics with product offerings to create value-added services that improve detection, decision support, and performance monitoring, thereby strengthening customer relationships and retention. Fifth, focus talent development on cross-functional teams that can navigate scientific, regulatory, and commercialization challenges while maintaining adaptive learning cultures.

Finally, proactively engage with regulators, policymakers, and civil society stakeholders to build transparency around safety data, environmental assessments, and socioeconomic benefits. Such engagement can reduce uncertainty, improve public acceptance, and create pathways for pragmatic regulatory harmonization that supports responsible innovation at scale.

A transparent, interdisciplinary research approach combining expert interviews, literature synthesis, and robust validation to ensure actionable and verifiable insights

The research methodology underpinning this analysis combined qualitative and quantitative approaches designed to ensure robustness, transparency, and reproducibility. Primary research included structured interviews with senior R&D leaders, regulatory specialists, procurement officers, and farmer representatives to capture lived experience across development pipelines, supply chains, and adoption dynamics. These interviews were supplemented by consultations with policy experts and technical advisers who provided context on evolving regulatory frameworks and trade policy impacts.

Secondary analysis drew upon peer-reviewed literature, government and intergovernmental publications, technical white papers, and publicly available company disclosures to triangulate findings and validate technical assertions. Data quality assurance included cross-referencing multiple independent sources, applying consistency checks to technology classification, and subjecting preliminary conclusions to expert review panels. Limitations were acknowledged and addressed by transparently documenting assumptions related to technology readiness, regulatory timelines, and supply chain configurations.

Overall, the methodological approach emphasized interdisciplinary evidence synthesis, stakeholder validation, and iterative refinement to produce insights that are practical for decision-makers while grounded in verifiable information.

Synthesis of technological promise, supply chain resilience, and stakeholder engagement that defines a pragmatic path for realizing durable impact in agricultural biotechnology

In conclusion, the agricultural biotechnology landscape is maturing into a multifaceted ecosystem where scientific advances, regulatory alignment, supply chain resilience, and stakeholder engagement determine who succeeds. The convergence of gene editing, genomics, microbial solutions, and digital diagnostics is enabling targeted interventions that can materially improve resilience and productivity across diverse cropping systems and livestock sectors. However, translating scientific potential into durable market outcomes requires strategic orchestration across R&D, regulatory affairs, manufacturing, and market adoption efforts.

Trade policy shifts and tariff measures have underscored the importance of supply chain strategy and regional capability. At the same time, segmentation by technology, product type, crop focus, application, and end-user profile reveals differentiated pathways to impact that necessitate tailored business models and partnership strategies. Firms that invest in regulatory science, regional manufacturing, and integrated service offerings while maintaining transparent stakeholder engagement will be best positioned to realize commercial and societal benefits.

Ultimately, the pathway forward is one of pragmatic innovation: aligning technological promise with feasible deployment strategies, responsible governance, and a clear focus on end-user value.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Agricultural Biotechnology Market, by Product Type

  • 8.1. Animal Biotechnology Products
  • 8.2. Biofertilizers
  • 8.3. Biopesticides
  • 8.4. Genetically Modified (GM) Crops / Transgenic Seeds
  • 8.5. Plant Growth Regulators

9. Agricultural Biotechnology Market, by Technology

  • 9.1. Bioinformatics
  • 9.2. Genetic Engineering
    • 9.2.1. CRISPR/Cas9 & Gene Editing
    • 9.2.2. Transgenic Technology
  • 9.3. Genomics and Molecular Markers
    • 9.3.1. DNA Sequencing
    • 9.3.2. Marker-Assisted Selection (MAS)
  • 9.4. Microbial Biotechnology
  • 9.5. Molecular Diagnostics
  • 9.6. Synthetic Biology
  • 9.7. Tissue Culture

10. Agricultural Biotechnology Market, by Crop Type

  • 10.1. Cereals
    • 10.1.1. Barley
    • 10.1.2. Maize
    • 10.1.3. Rice
    • 10.1.4. Wheat
  • 10.2. Fruits & Vegetables
  • 10.3. Oilseeds
    • 10.3.1. Rapeseed
    • 10.3.2. Soybean
    • 10.3.3. Sunflower
  • 10.4. Pulses
    • 10.4.1. Chickpea
    • 10.4.2. Lentil
    • 10.4.3. Pea

11. Agricultural Biotechnology Market, by Application

  • 11.1. Crop Improvement
    • 11.1.1. Abiotic Stress Tolerance
    • 11.1.2. Pest Resistance
    • 11.1.3. Yield Enhancement
  • 11.2. Disease Management
  • 11.3. Environmental Sustainability
  • 11.4. Livestock Health & Productivity
  • 11.5. Soil Fertility Management

12. Agricultural Biotechnology Market, by End-user

  • 12.1. Agricultural Cooperatives
  • 12.2. Biotech Companies
  • 12.3. Farmers & Growers
  • 12.4. Government & Regulatory Agencies
  • 12.5. Research Institutions
  • 12.6. Seed Manufacturers

13. Agricultural Biotechnology Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Agricultural Biotechnology Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Agricultural Biotechnology Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Agricultural Biotechnology Market

17. China Agricultural Biotechnology Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. ADAMA Ltd
  • 18.6. Agrinos AS
  • 18.7. Andermatt Biocontrol AG
  • 18.8. Arcadia Biosciences, Inc.
  • 18.9. BASF SE
  • 18.10. Bayer CropScience AG
  • 18.11. Bioworks, Inc.
  • 18.12. Certis USA LLC
  • 18.13. CIBO Technologies, Inc.
  • 18.14. Corteva, Inc.
  • 18.15. Evogene Ltd.
  • 18.16. FMC Corporation
  • 18.17. Indigo Ag, Inc.
  • 18.18. Koppert Biological Systems NV
  • 18.19. KWS SAAT SE & Co. KGaA
  • 18.20. Limagrain
  • 18.21. Marrone Bio Innovations, Inc.
  • 18.22. Nufarm Limited
  • 18.23. Performance Plants Inc.
  • 18.24. Pivot Bio, Inc.
  • 18.25. Symbiomics S.A.
  • 18.26. Syngenta AG
  • 18.27. UPL Limited
  • 18.28. Valent BioSciences LLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL BIOTECHNOLOGY PRODUCTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL BIOTECHNOLOGY PRODUCTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL BIOTECHNOLOGY PRODUCTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOFERTILIZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOFERTILIZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOFERTILIZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOPESTICIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOPESTICIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOPESTICIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENETICALLY MODIFIED (GM) CROPS / TRANSGENIC SEEDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENETICALLY MODIFIED (GM) CROPS / TRANSGENIC SEEDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENETICALLY MODIFIED (GM) CROPS / TRANSGENIC SEEDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PLANT GROWTH REGULATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PLANT GROWTH REGULATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PLANT GROWTH REGULATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOINFORMATICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOINFORMATICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CRISPR/CAS9 & GENE EDITING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CRISPR/CAS9 & GENE EDITING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CRISPR/CAS9 & GENE EDITING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TRANSGENIC TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TRANSGENIC TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TRANSGENIC TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENOMICS AND MOLECULAR MARKERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENOMICS AND MOLECULAR MARKERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENOMICS AND MOLECULAR MARKERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENOMICS AND MOLECULAR MARKERS, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY DNA SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY DNA SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MARKER-ASSISTED SELECTION (MAS), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MARKER-ASSISTED SELECTION (MAS), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MARKER-ASSISTED SELECTION (MAS), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MICROBIAL BIOTECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MICROBIAL BIOTECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MICROBIAL BIOTECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SYNTHETIC BIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SYNTHETIC BIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SYNTHETIC BIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TISSUE CULTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TISSUE CULTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TISSUE CULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CEREALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CEREALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CEREALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CEREALS, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BARLEY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BARLEY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BARLEY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MAIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MAIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY MAIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY RICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY RICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY RICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY WHEAT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY WHEAT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY WHEAT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY FRUITS & VEGETABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY FRUITS & VEGETABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY FRUITS & VEGETABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY OILSEEDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY OILSEEDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY OILSEEDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY OILSEEDS, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY RAPESEED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY RAPESEED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY RAPESEED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SOYBEAN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SOYBEAN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SOYBEAN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SUNFLOWER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SUNFLOWER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SUNFLOWER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PULSES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PULSES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PULSES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PULSES, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CHICKPEA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CHICKPEA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CHICKPEA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY LENTIL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY LENTIL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY LENTIL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PEA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PEA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PEA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY ABIOTIC STRESS TOLERANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY ABIOTIC STRESS TOLERANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY ABIOTIC STRESS TOLERANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PEST RESISTANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PEST RESISTANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PEST RESISTANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY YIELD ENHANCEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY YIELD ENHANCEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY YIELD ENHANCEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY DISEASE MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY DISEASE MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY DISEASE MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY ENVIRONMENTAL SUSTAINABILITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY ENVIRONMENTAL SUSTAINABILITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY ENVIRONMENTAL SUSTAINABILITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY LIVESTOCK HEALTH & PRODUCTIVITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY LIVESTOCK HEALTH & PRODUCTIVITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY LIVESTOCK HEALTH & PRODUCTIVITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SOIL FERTILITY MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SOIL FERTILITY MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SOIL FERTILITY MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY AGRICULTURAL COOPERATIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY AGRICULTURAL COOPERATIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY AGRICULTURAL COOPERATIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOTECH COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY BIOTECH COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY FARMERS & GROWERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY FARMERS & GROWERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY FARMERS & GROWERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GOVERNMENT & REGULATORY AGENCIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GOVERNMENT & REGULATORY AGENCIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GOVERNMENT & REGULATORY AGENCIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SEED MANUFACTURERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SEED MANUFACTURERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SEED MANUFACTURERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 146. AMERICAS AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 147. AMERICAS AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. AMERICAS AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 149. AMERICAS AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 150. AMERICAS AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENOMICS AND MOLECULAR MARKERS, 2018-2032 (USD MILLION)
  • TABLE 151. AMERICAS AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. AMERICAS AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CEREALS, 2018-2032 (USD MILLION)
  • TABLE 153. AMERICAS AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY OILSEEDS, 2018-2032 (USD MILLION)
  • TABLE 154. AMERICAS AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PULSES, 2018-2032 (USD MILLION)
  • TABLE 155. AMERICAS AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. AMERICAS AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, 2018-2032 (USD MILLION)
  • TABLE 157. AMERICAS AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENOMICS AND MOLECULAR MARKERS, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. NORTH AMERICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CEREALS, 2018-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY OILSEEDS, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PULSES, 2018-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENOMICS AND MOLECULAR MARKERS, 2018-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CEREALS, 2018-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY OILSEEDS, 2018-2032 (USD MILLION)
  • TABLE 178. LATIN AMERICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PULSES, 2018-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. LATIN AMERICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, 2018-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENOMICS AND MOLECULAR MARKERS, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CEREALS, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY OILSEEDS, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PULSES, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENOMICS AND MOLECULAR MARKERS, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CEREALS, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY OILSEEDS, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PULSES, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENOMICS AND MOLECULAR MARKERS, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CEREALS, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY OILSEEDS, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PULSES, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, 2018-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENOMICS AND MOLECULAR MARKERS, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CEREALS, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY OILSEEDS, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PULSES, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 230. ASIA-PACIFIC AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENOMICS AND MOLECULAR MARKERS, 2018-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CEREALS, 2018-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY OILSEEDS, 2018-2032 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PULSES, 2018-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, 2018-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 242. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 243. ASEAN AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 244. ASEAN AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. ASEAN AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 246. ASEAN AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 247. ASEAN AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENOMICS AND MOLECULAR MARKERS, 2018-2032 (USD MILLION)
  • TABLE 248. ASEAN AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CEREALS, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY OILSEEDS, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PULSES, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 253. ASEAN AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, 2018-2032 (USD MILLION)
  • TABLE 254. ASEAN AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 255. GCC AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 256. GCC AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. GCC AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 258. GCC AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 259. GCC AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENOMICS AND MOLECULAR MARKERS, 2018-2032 (USD MILLION)
  • TABLE 260. GCC AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 261. GCC AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CEREALS, 2018-2032 (USD MILLION)
  • TABLE 262. GCC AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY OILSEEDS, 2018-2032 (USD MILLION)
  • TABLE 263. GCC AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PULSES, 2018-2032 (USD MILLION)
  • TABLE 264. GCC AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 265. GCC AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, 2018-2032 (USD MILLION)
  • TABLE 266. GCC AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPEAN UNION AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPEAN UNION AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPEAN UNION AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENOMICS AND MOLECULAR MARKERS, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPEAN UNION AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CEREALS, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPEAN UNION AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY OILSEEDS, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PULSES, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPEAN UNION AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPEAN UNION AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 279. BRICS AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 280. BRICS AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 281. BRICS AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 282. BRICS AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 283. BRICS AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENOMICS AND MOLECULAR MARKERS, 2018-2032 (USD MILLION)
  • TABLE 284. BRICS AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 285. BRICS AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CEREALS, 2018-2032 (USD MILLION)
  • TABLE 286. BRICS AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY OILSEEDS, 2018-2032 (USD MILLION)
  • TABLE 287. BRICS AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PULSES, 2018-2032 (USD MILLION)
  • TABLE 288. BRICS AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 289. BRICS AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, 2018-2032 (USD MILLION)
  • TABLE 290. BRICS AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 291. G7 AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 292. G7 AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 293. G7 AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 294. G7 AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 295. G7 AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GENOMICS AND MOLECULAR MARKERS, 2018-2032 (USD MILLION)
  • TABLE 296. G7 AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 297. G7 AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CEREALS, 2018-2032 (USD MILLION)
  • TABLE 298. G7 AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY OILSEEDS, 2018-2032 (USD MILLION)
  • TABLE 299. G7 AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PULSES, 2018-2032 (USD MILLION)
  • TABLE 300. G7 AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 301. G7 AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY CROP IMPROVEMENT, 2018-2032 (USD MILLION)
  • TABLE 302. G7 AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 303. NATO AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 304. NATO AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 305. NATO AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD